Human CD34+ iPSC Expansion Bundle

Cellular Engineering Technologies

SKU: CET-BR1009

Cryopreserved vial of human CD34+ cord blood iPS cells containing ≥ 500,000 cells and companion iPS Cell Growth Media Kit

Human CD34+ iPSC Starter Kit

The Human CD34+ iPSC Starter Kit provides a complete solution for researchers studying hematopoietic stem cell differentiation, disease modeling, and regenerative medicine. This bundle includes CD34+ Hematopoietic Stem Cell-Derived iPSCs (CET-CR1003-500) and Human iPSC Growth Media Kit (CET-MR1001-K), ensuring a reliable and reproducible platform for stem cell expansion and maintenance.

Kit Components:

• Human CD34+ Induced Pluripotent Stem Cell (iPSC) Line (CET-CR1003-500)
  • Derived from cord blood hematopoietic stem cells (HSCs) using a non-integrating, virus-free episomal reprogramming method for enhanced genomic stability.
  • Exhibits a high proliferation rate, rapid doubling time (~20 hours), and robust pluripotency, making it ideal for blood and immune cell differentiation.
  • Maintains a clean genetic profile without chromosomal abnormalities or unwanted mutations.
  • Each vial contains ~500,000 viable cells, shipped on dry ice for maximum stability.
• Human iPSC Growth Media Kit (CET-MR1001-K)
  • Serum-free and xeno-free formulation designed to maintain pluripotency while preventing spontaneous differentiation.
  • Compatible with a range of extracellular matrices, including Vitronectin XF, Geltrex, and Matrigel, ensuring adaptability across various research protocols.
  • Ready-to-use with no additional additives required, providing a consistent and reproducible culture environment.
  • Includes iPSC Basal Media (500mL) and iPSC Growth Supplement (7mL), shipped with gel packs and dry ice for optimal storage and transportation.

Applications:

• Hematopoietic Differentiation: Generate blood and immune cells such as erythrocytes, T cells, B cells, and NK cells.
• Disease Modeling: Study hematopoietic disorders, leukemia, sickle cell disease, and immunodeficiencies.
• Drug Discovery & Toxicology: Screen drug candidates for hematopoietic diseases and assess immune-modulating therapies.
• Cell Therapy Research: Investigate CD34+ iPSC-derived cells for potential applications in bone marrow transplantation and regenerative medicine.

The Human CD34+ iPSC Starter Kit delivers a high-performance, reproducible system for researchers in hematopoietic stem cell biology and regenerative medicine.